Company news: Johnson & Johnson's (JNJ) quarterly earnings beat analysts’ estimates

Johnson & Johnson (JNJ) reported Q4 FY2024 earnings of $2.04 per share (versus $2.29 per share in Q4 FY2023), beating analysts’ consensus estimate of $2.01 per share.

The company’s quarterly revenues amounted to $22.520 bln (+5.3% y/y), roughly matching analysts’ consensus estimate of $22.446 bln.

The company also issued guidance for FY2025, seeing EPS of $10.50-10.70 versus analysts’ consensus estimate of $10.55 and revenues of $90.9-91.7 bln versus analysts’ consensus estimate of $91.04 bln. 

Johnson & Johnson CEO Joaquin Duato acknowledged there are some 2025 headwinds such as the Chinese economy, more competition for larger products and a stronger dollar, but noted that he is optimistic about President Trump's administration. 

JNJ fell to $145.97 (-1.47%) in pre-market trading.